News Details

Athersys and University Hospitals Cleveland Medical Center Announce Activation of the First Clinical Site for the MACOVIA Study, a Pivotal Phase 2/3 Study Evaluating MultiStemĀ® Cell Therapy for COVID-19 Induced ARDS

About Athersys, Inc.

Price Chart